A5023514450- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Cardiomyopathy and Myosin Studies
- Vascular Procedures and Complications
- Peripheral Artery Disease Management
- Cardiovascular Issues in Pregnancy
- Electrospun Nanofibers in Biomedical Applications
- Microfluidic and Capillary Electrophoresis Applications
- Trypanosoma species research and implications
- Central Venous Catheters and Hemodialysis
- Tissue Engineering and Regenerative Medicine
- Reconstructive Surgery and Microvascular Techniques
- Nanofabrication and Lithography Techniques
- Cerebrovascular and Carotid Artery Diseases
- Mesenchymal stem cell research
- Innovations in Medical Education
- Aortic aneurysm repair treatments
- Cardiovascular Effects of Exercise
- Advanced Materials Characterization Techniques
- Cardiovascular Function and Risk Factors
- Medical Education and Admissions
Georgetown University
2022-2025
Abstract Background The use of vascular closure devices (VCDs) to achieve quick and safe hemostasis after femoral arterial access is widely accepted. Major complications include bleeding occlusion the artery due device failure, which often necessitates intervention. This manuscript details our peripheral percutaneous endovascular interventional (PEI) approach for management resulting from Angio‐Seal (Terumo, Somerset, New Jersey, USA) VCD deployment. Methods Consecutive patients who...
Leadless pacemakers (LPs) are emerging options for bradyarrhythmias. However, extraction can be risky if the device is in an unfavorable position. We present a challenging case of Nanostim LP (NLP) (Abbott Medical Inc., Abbott Park, IL, USA) placed 8 years prior to removal and subsequent replacement with AVEIR (ALP) (Abbott). A 72-year-old man received NLP 2015 persistent atrial fibrillation bradycardia. The could not interrogated our office. An external event monitor demonstrated...
Myocardial infarction (MI) poses a significant burden to both patients and the health care system. The irreversible loss of functional cardiomyocytes due ischemia threatens patients’ immediate survival quality life over their lifespan. Stem cell therapy has been proposed as solution salvage cardiac contractility through regeneration cardiomyocytes, bone marrow–derived stem cells (BMSc) are among category most extensively studied. Despite promising theoretical potential BMSc in tissue...